Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 22Multiple Myeloma 11Neoplasm Metastasis 9Pain 8Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Bone Neoplasms 5Osteoporosis 4Fractures, Bone 4Bone Diseases 4Lung Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Humoral Hypercalcemia Of Malignancy 2Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Pleural Effusion, Malignant 1Paraproteinemias 1Neoplastic Processes 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Neoplasms 1Hematologic Diseases 1Disease Progression 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 71Etoposide 63Topotecan 42Cisplatin 38pembrolizumab 30atezolizumab 26durvalumab 22Paclitaxel 16Nivolumab 14PM 01183 13rovalpituzumab tesirine 11Pemetrexed 11amrubicin 9Ipilimumab 9Injections 9Irinotecan 8AMG 757 8trilaciclib 7etoposide phosphate 6EC regimen 6Drug Therapy 6Docetaxel 6Bevacizumab 6tremelimumab 5MLN 8237 5Gemcitabine 5130-nm albumin-bound paclitaxel 5olaparib 4chiauranib 4budigalimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Small Cell Lung Carcinoma × Zoledronic Acid × Clear all
NCT00003884 2013-02-21

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Novartis

Phase 3 Completed
600 enrolled
Thoracic

Humoral Hypercalcemia Of Malignancy, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡